Developmental Research Program

发展研究计划

• 批准号: 10709235
• 负责人: ROBERT C BAST
• 金额: $ 8.52万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-19 至 2028-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10709235
• 关键词: Address; Ally; Area; Award; Basic Science; Budgets; Cancer Center; Clinical; Clinical Investigator; Clinical Research; Collaborations; Data; Dedications; Department of Defense; Development; Discipline; Disease; Early Diagnosis; Early treatment; Financial Support; Foundations; Funding; Funding Mechanisms; Future; Goals; Human; Incidence; Institution; Malignant Neoplasms; Malignant neoplasm of ovary; Manuscripts; Medical center; Ovarian; Peer Review; Population Research; Prevention; Productivity; Program Research Project Grants; Publishing; Quality of life; Research; Research Personnel; Research Project Grants; Resources; Rest; Scientist; Specimen; Texas; Translational Research; University of Texas M D Anderson Cancer Center; Woman; Work; anticancer research; candidate identification; design; improved; innovation; mortality; novel; ovarian cancer prevention; patient population; peer; programs; supportive environment; translational potential; translational study

Developmental Research Program SUMMARY/ABSTRACT The purpose of the Developmental Research Program (DRP) is to fund promising projects by investigators whose current work may not focus exclusively on ovarian cancer, but who propose highly innovative translational studies of ovarian cancer that could become full SPORE projects or compete successfully for funding outside of the SPORE. The DRP provides a unique opportunity for making available significant financial support, and for demonstrating active institutional support, through a program that is rapidly responsiveto new ideas or initiatives. Moreover, this program is rooted in a spirit of collaboration promoted by the SPORE investigators who have an extensive track record of bringing investigators from other disciplines into ovarian cancer research. The strength of the DRP rests in its ability to make available financial support needed to access all the critical expertise and resources within the entire SPORE. This will allow us to develop collaborative, multi-investigator, multi-institutional research projects with the support of innovative, investigator- initiated projects that have the potential to flourish into reliable and productive translational research projects that make a path from basic and/or population research projects into research focused on human clinical specimens/patient populations. Over the course of the past decade, the MD Anderson OvarianSPORE has supported DRP projects from 22 investigators. Collectively, these investigators have published 470 peer- reviewed manuscripts related to ovarian cancer. Thirteen of the recipients have received peer-reviewedfunding in ovarian cancer as either PI, Co-PI or Co-Investigator. The investigators have received funding from three R01s, three R21s, three CPRIT awards, two Department of Defense Awards and four OCRA awards. One awardee in the most recently funded cycle just received support from both the Ovarian Cancer Research Alliance and Foundation for Women’s Cancer. Additionally, three former awardees have participated in full SPORE projects after completing a DRP project.

发展研究计划摘要/摘要